3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
4
Neoplasms
3
Multiple Myeloma
3
Gastrointestinal Stromal Tumors
3
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Dexamethasone
2
Calcium Dobesilate
2
Biopsy
2
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
2
venetoclax
1
ixazomib
1
daratumumab
1
belantamab mafodotin
1
X-Rays
1
Stem Cell Transplantation
1
Phantoms, Imaging
1
Melphalan
1
Cyclophosphamide
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Sunitinib
×
30 days
×
Clear all
No trials found.